Injective (INJ) is currently trading at $3.11, showing a 5.29% increase over the past 24 hours. The price has fluctuated between a low of $2.95 and a high of $3.14 during this period, indicating a daily range of 0.19%, which suggests relatively low volatility.

The trading volume stands at approximately $57 million, equating to 18.35% of its market cap, reflecting a healthy level of liquidity. However, despite the recent uptick in price, the 7-day RSI is neutral at 50, and the asset has seen a negative price change of 7.32% over the last week, indicating potential weakness in upward momentum.

The hourly moving averages suggest bullish short-term sentiment, with the 8 SMA at $3.06 reflecting a gain of 1.68% and the 13 SMA at $3.04 showing a 2.24% increase. However, the 144 SMA at $3.12 has a slight decline of 0.47%, which may signal a resistance level that needs to be breached for sustained upward movement.

From a longer-term perspective, INJ has faced significant downward pressure, with a 30-day price change of -10.63%. The all-time high of $52.62, reached in March 2024, sets a stark contrast to the current price and indicates a substantial potential for recovery should market conditions improve.

Given the mixed signals from technical indicators and the recent price performance, the recommendation for Injective (INJ) is to Hold. This strategy allows investors to monitor the price action and market sentiment before making further decisions, particularly given the asset's potential to either recover or continue its downtrend based on broader market movements.